Domstol beslagtar Wu-Tang-skiva från Shkreli
Martin Shkreli blev en av USA:s mest avskydda människor när han som läkemedels-vd köpte rättigheterna till ett läkemedel som bland annat används av aidspatienter och chockhöjde priset med 5 000 procent. Nu har en domstol i New York lagt beslag på hans dyrbaraste tillgångar – bland annat det enda exemplaret av hiphopkollektivet Wu-Tang Clans album "Once upon a time in Shaolin". Det skriver The Guardian.
Martin Shkreli står sedan tidigare åtalad för bedrägeri. Vid en auktion 2015 betalade han 17 miljoner kronor för albumet.
bakgrund
Martin Shkreli
Wikipedia (en)
Martin Shkreli (; born March 17, 1983) is an American businessman, former hedge fund manager, and convicted, currently incarcerated felon. He is the co-founder of the hedge funds Elea Capital, MSMB Capital Management, and MSMB Healthcare; co-founder and former chief executive officer (CEO) of the biotechnology firm Retrophin; and founder and former CEO of Turing Pharmaceuticals. Shkreli is also the CEO of start-up software company Gödel Systems, which he founded in August 2016.
In September 2015, Shkreli received widespread criticism when Turing obtained the manufacturing license for the antiparasitic drug Daraprim and raised its price by a factor of 56 (from US$13.5 to US$750 per pill), leading him to be referred to as "the most hated man in America" and "Pharma Bro".
In December 2015, Shkreli was arrested by the FBI after being indicted on federal charges of securities fraud. He subsequently resigned as CEO of Turing Pharmaceuticals and was replaced by the company's board chairman, Ron Tilles. Shkreli was convicted of two counts of securities fraud and one count of conspiring to commit securities fraud in August 2017.
Omni är politiskt obundna och oberoende. Vi strävar efter att ge fler perspektiv på nyheterna. Har du frågor eller synpunkter kring vår rapportering? Kontakta redaktionen
